SELLAS Life Sciences Grou... (SLS)
NASDAQ: SLS
· Real-Time Price · USD
1.62
0.07 (4.52%)
At close: Aug 15, 2025, 3:59 PM
1.62
0.19%
After-hours: Aug 15, 2025, 07:58 PM EDT
SELLAS Life Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.6M | -5.81M | -6.74M | -7.11M | -7.47M | -9.57M | -8.14M | -9.27M | -8.84M | -11.1M | -9.12M | -7.02M | -8.41M | -16.74M | -6.6M | -7.08M | -4.61M | -2.4M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 158K | 87K | 123K | 207K | 82K | 45K | 5.42M | n/a | n/a | 846K |
Stock-Based Compensation | 501K | 505K | 373K | 381K | 334K | 476K | 497K | 543K | 514K | 540K | 446K | 455K | 450K | 375K | 288K | 275K | 264K | 184K |
Other Working Capital | n/a | -4.19M | 181K | 552K | -566K | -3.62M | 1.37M | 1.1M | -57K | 284K | 1.34M | 1.84M | 1.76M | -504K | 885K | 553K | 1.62M | -8.16M |
Other Non-Cash Items | -1.23M | 147K | 148K | 137K | -921K | 138K | 128K | 122K | 156K | 85K | -44K | 194K | -81K | 10.06M | -4.57M | 110K | -684K | 975K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -158K | -87K | -123K | -207K | -82K | n/a | -239 | n/a | n/a | -815K |
Change in Working Capital | n/a | -3.91M | -937K | -1.22M | -1.63M | -1.81M | 2.69M | 1.71M | 604K | -1.66M | 3.57M | 627K | 2.28M | -837K | 484K | 822K | 135K | -9.06M |
Operating Cash Flow | -7.33M | -9.07M | -7.15M | -7.81M | -9.68M | -10.76M | -4.83M | -6.89M | -7.57M | -12.13M | -5.15M | -5.75M | -5.76M | -7.15M | -4.98M | -5.88M | -4.9M | -10.27M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -5.5M | -3M | n/a | n/a | -4.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 5.5M | n/a | -2.5M | n/a | 4.5M | -4.5M | -4.5M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3M | -2.5M | n/a | -4.5M | -4.5M | -4.5M | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.23M | n/a | -63K | 202K | 355K | 100K | -17K | n/a | n/a | 53K | -85K | 38K | n/a | 47K | 50K | 2K | 17K | 3M |
Financial Cash Flow | 4.23M | 23.58M | 8K | 19.69M | 414K | 26.65M | 3.39M | 54K | -29K | 18.9M | 929K | 107K | 23M | 47K | 50K | 2.24M | 6.78M | 3M |
Net Cash Flow | -3.1M | 14.51M | -7.14M | 11.88M | -9.27M | 15.88M | -1.44M | -9.84M | -10.1M | 6.78M | -4.22M | -5.64M | 12.73M | -7.1M | -4.93M | -3.64M | 1.88M | -7.27M |
Free Cash Flow | -7.33M | -9.07M | -7.15M | -7.81M | -9.68M | -10.76M | -10.32M | -9.89M | -7.57M | -12.13M | -9.65M | -5.75M | -5.76M | -7.15M | -4.98M | -5.88M | -4.9M | -10.27M |